Amgen Inc - Company Profile
Powered by 
All the data and insights you need on Amgen Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Amgen Inc Strategy Report
- Understand Amgen Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View moreView up-to-date information on Amgen Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP4058859A1 | Application | OFFLINE-FEHLERBEHEBUNG UND ENTWICKLUNG FÜR AUTOMATISIERTE VISUELLE KONTROLLSTATIONEN | G01N21/8803; G05B19/41875; G05B2219/37009; G06T7/001 | September 21, 2022 |
| EP4058148A1 | Application | DOSIERSCHEMA FÜR ANTI-BCMA-WIRKSTOFFE | A61K2039/505; A61K2039/545; A61K9/0019; A61P35/00; C07K16/2809; C07K16/2878; C07K2317/31; C07K2317/565; C07K2317/622; C07K2317/94 | September 21, 2022 |
| EP4058432A1 | Application | VERBESSERTE SYNTHESE EINER KRAS-G12C-HEMMENDEN VERBINDUNG | C07D213/73; C07D213/85 | September 21, 2022 |
| EP2352763B2 | Grant | BISPEZIFISCHER EINZELKETTENANTIKÖRPER MIT SPEZIFITÄT FÜR HOCHMOLEKULARE TARGET-ANTIGENE | A61K2039/505; A61K39/39558; A61P35/00; A61P35/02; C07K16/005; C07K16/2809; C07K16/2851; C07K16/2863; C07K16/3069; C07K2317/31; C07K2317/34; C07K2317/622; C07K2317/732; C12N15/1037 | September 21, 2022 |
| EP4058485A1 | Application | VERFAHREN ZUR VERRINGERUNG DER AGGREGATBILDUNG BEI DER NACHGELAGERTEN VERARBEITUNG VON BISPEZIFISCHEN ANTIGEN-BINDENDEN MOLEKÜLEN | A61K39/39525; A61K39/39591; C07K1/34; C07K16/2803; C07K16/2809; C07K2317/31; C07K2317/34; C07K2317/624 | September 21, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer